Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

Share

March 08, 2022; 98 (10) Resident & Fellow Section

Clinical Reasoning: Longitudinally Extensive Spinal Cord Lesions in a Middle-aged Man

Nina Xie, Yafang Zhou
First published December 22, 2021, DOI: https://doi.org/10.1212/WNL.0000000000013260
Nina Xie
From the Department of Geriatric Neurology (N.X., Y.Z.), Xiangya Hospital, Central South University; and National Clinical Research Center for Geriatric Disorders (N.X., Y.Z.), Changsha, Hunan, China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yafang Zhou
From the Department of Geriatric Neurology (N.X., Y.Z.), Xiangya Hospital, Central South University; and National Clinical Research Center for Geriatric Disorders (N.X., Y.Z.), Changsha, Hunan, China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
Clinical Reasoning: Longitudinally Extensive Spinal Cord Lesions in a Middle-aged Man
Nina Xie, Yafang Zhou
Neurology Mar 2022, 98 (10) 419-424; DOI: 10.1212/WNL.0000000000013260

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
1175

Share

  • Article
  • Figures & Data
  • Info & Disclosures
Loading

Abstract

An immunocompetent 47-year-old man presented with a five-month history of progressive lower limb weakness, back pain, sphincter dysfunction, and intermittent fever, suggesting myelopathy in a chronic deteriorating course. A comprehensive analysis comprising of blood tests, neuroimaging, CSF profiling, molecular analysis, and histopathology was performed. Notably, enhanced spinal cord MRI revealed longitudinally extensive intradural-extramedullary lesions involving the cervical, thoracic, and lumbosacral spinal cord, with homogeneous enhancement and spinal cord compression. Serum treponema pallidumhemagglutination (TPHA) and rapid plasma reagin (RPR) tests were positive. CSF profiling showed pleocytosis, significant protein elevations, hypoglycorrhachia, and positive TPHA test. 18F-FDG-PET/CT indicated slightly increased intraspinal fluorodeoxyglucose (FDG) uptake. Spinal cord biopsy further showed small round blue cells in poorly differentiated tissues. Immunostaining was positive for NKX2.2, CD56, CD99, Synaptophysin, and Ki67 (50%). Molecular analysis detected a novel MALAT-CYSLTR1 fusion protein and variants in oncogenic genes including PTCH1, TERT, CREBBP, SPEN, and STK11. The diagnosis of intraspinal extraosseous Ewing sarcoma (ES) was confirmed. Briefly, our case details the diagnosis of a patient with intradural-extramedullary ES and highlights the value of spinal cord biopsy in progressive myelopathy of unknown causes.

Section 1

An immunocompetent 47-year-old man presented with a five-month history of worsening lower limb weakness. Initially, he noticed numbness and weakness in the left leg and had slight gait difficulty. Over the next 5 months, the symptoms progressed to the right leg, to the point of being unable to walk. Two weeks ago, he also developed neck pain, urinary retention, and constipation. The pain was severe and persistent, radiating into the shoulders and lumbosacral region. One week before, he experienced intermittent fever. On physical examination, he was alert and oriented, with a temperature of 38.2°C and nuchal rigidity. Cranial nerves were intact. The strength and tone of upper limbs were normal. Lower limb strength was rated 0/5 bilaterally, with decreased muscle tone. Deep tendon reflexes of the upper limbs were rated 2+. Lower limbs were areflexic. Abdominal reflexes were bilaterally absent. Babinski sign was present bilaterally. There was no ankle clonus. Sensation to pinprick and vibration were diminished below the sternal angle, suggesting a T2 sensory level.

Questions for Consideration:

  1. Where would you localize the lesion?

  2. What is your initial investigation approach?

GO TO SECTION 2

Section 2

Progressive lower limb weakness, sphincter dysfunction, and T2 sensory level are classic features of myelopathy. Longitudinally, the neck pain, T2 sensory level, absence of abdominal reflexes, and flaccid paralysis in lower limbs suggested involvement of the cervical, thoracic, and lumbosacral segments. Transversely, impaired structures may include anterior horns (areflexic lower limbs), posterior funiculus (diminished vibratory sensation), corticospinal tracts (presence of Babinski sign), posterior horn, and spinothalamic tracts (diminished sensation to pinprick). Temporally, because this patient has a chronic deteriorating course, disorders that worsen rapidly such as spinal cord infarction or disc herniation were less likely. Taken together, longitudinally extensive transverse myelopathy with a chronic deteriorating course should be considered at this stage. Differential diagnoses include infection, neoplasms, sarcoidosis, spinal arteriovenous fistula, demyelination, and metabolic disorders. The initial investigation approach should include routine screenings for these etiologies, as well as CSF analysis and enhanced cerebrospinal MRI.

Blood tests were notable for increased inflammatory markers and positive syphilis antibodies (eTable 1, links.lww.com/WNL/B734). Pulmonary CT and ECG were unremarkable. Enhanced brain and spinal cord MRI revealed longitudinally extensive lesions involving the cervical, thoracic, and lumbosacral spinal cord. The spinal cord was compressed, slightly hypointense on T1-weighted images, and hyperintense on T2-weighted images. The lesions were posterior to the spinal cord, iso-to hyperintense on T1-weighted images and hypointense on T2-weighted images, with well-defined borders and homogeneous enhancement (Figure 1). On lumbar puncture, CSF pressure was 390 mmH2O. Less than 2 mL of yellow-colored CSF was collected because of hypercoagulability. CSF profiling showed pleocytosis (total cell count 120*10^6/L, a white blood cell count 12*10^6/L, polynuclear cells 60%), significant protein elevations (5.56 g/L), decreased glucose levels (1.6 mmol/L), a positive TPHA test, and a negative rapid plasma reagin test. Blood, urine, and stool cultures detected no bacteria or fungi, nor did the result of CSF next-generation sequencing.

Figure 1
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1 Spinal Cord MRI

(A-C) Cervical T1WI, T2WI, and enhanced spinal cord MRI. (D–F) Thoracic T1WI, T2WI, and enhanced spinal cord MRI. (G–I) Lumbosacral T1WI, T2WI, and enhanced spinal cord MRI.

Question for Consideration:

  1. What is your differential diagnosis at this stage?

GO TO SECTION 3

Section 3

The ascending sensory disturbance, late-onset sphincter dysfunctions, significantly elevated CSF protein levels, and unique spinal MRI findings suggested an intradural-extramedullary lesion extending through multiple segments. In addition, the CSF hyperproteinosis, xanthochromia, and hypercoagulability indicated Froin syndrome, which together with the CSF pleocytosis and hypoglycorrhachia are highly suggestive of infectious or neoplastic disorders.

Infections that can form long segmental abscesses or granulomas in the subdural space need to be considered. Tuberculosis, fungus, and brucella were excluded as the exposure history, and relevant pathogen tests were negative. The patient was positive for TPHA in both serum and CSF, suggesting neurosyphilis. Antisyphilitic treatment with penicillin was indicated. However, the spinal MRI findings of our patient were very uncommon for neurosyphilis. Pathologically, intradural-extramedullary syphilitic myelopathy is most likely caused by syphilitic gumma.1 The MRI findings typically present as short-segment T2 hyperintensities, with nodular or ring-like enhancement.2,-,6 The “flip-flop” sign, an enhanced lesion shown as hypointense signals on T2-weighted images, and the “candle guttering” sign, a flame-like enhancement of the spinal parenchyma beneath the pia mater, were thought to be characteristic.4,5 Our patient's MRI lacked most of the above features.

The avid contrast enhancement on MRI and CSF changes prompt the consideration of intradural-extramedullary neoplasms. Neurofibroma, lymphoma, myxopapillary ependymoma, and spinal metastasis are not very likely, although they can cause long segmental lesions with clear margination and enhancement. Their lesions are usually hypointense on T1-weighted images and hyperintense on T2-weighted images.7,8 Other neoplasms, such as melanotic schwannomas and extraosseous Ewing sarcoma, cannot be excluded because they can seem hyperintense on T1-weighted images and hypointense on T2-weighted images.7,9 Confirmatory diagnosis requires a biopsy.

Other diagnoses were less likely. Sarcoidosis can cause CSF changes similar to those in our patient. However, sarcoidosis typically presents as longitudinally extensive transverse myelitis with dorsal subpial enhancement.10 Intradural-extramedullary sarcoidosis is uncommon and seldom solely presents as myelopathy. Our patient lacked multisystemic manifestations such as hepatomegaly and hilar lymphadenopathy. The angiotensin converting enzyme levels and pulmonary CT were also unremarkable.

Spinal arteriovenous fistula (sAVF) can occur in the intradural-extramedullary space, spanning multiple continuous segments. Nevertheless, CSF glucose levels are often normal in sAVF. Spinal cord edema and tortuous vessels typically seem as diffuse hyperintensities and perimedullary flow voids on T2-weighted images, with linear, heterogeneous, or diffuse patchy enhancement.11 The CSF profiling and absence of flow void signals in our patient argued against sAVF.

The normal brain MRI, spared optic nerves, and negative antibodies excluded primary progressive multiple sclerosis and neuromyelitis optica spectrum disorder. The normal vitamin B12 and copper levels ruled out subacute combined degeneration and copper deficiency.

Question for Consideration:

  1. What would you do next?

GO TO SECTION 4

Section 4

To further distinguish between infection and neoplasm, whole-body PET/CT and spinal cord biopsy were indicated. The 18F-FDG-PET/CT indicated slightly increased intraspinal FDG uptake (SUVmax = 8.6) (Figure 1D). He underwent the surgery of laminectomy and spinal cord mass resection at the C6-T1 level. The tumor was 46*14*8 mm in size, projecting in the subarachnoid space and destroying the dorsal spinal cord. Histopathology showed small round blue cells microscopically. Immunostaining was positive for NKX2.2, CD56, CD99, synaptophysin, and Ki67 (50%) (Figure 2). Molecular analysis detected a MALAT-CYSLTR1 fusion protein and variants in oncogenic genes including PTCH1, TERT, CREBBP, SPEN, and STK11. The diagnosis of extraosseous Ewing sarcoma (ES) was confirmed.

Figure 2
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2 Histopathology and Immunostaining

(A) Hematoxylin and eosin staining showed small round blue cells (magnification ×200). Immunostaining was positive for (B) CD99, (C) NKX2.2, (D) CD56, (E) synaptophysin, and (F) Ki67 (magnification ×200).

Discussion

ES is an aggressive bone and soft-tissue cancer that occurs much more frequently in children than in adults. Tumors most often arise in the long bones of the limbs and pelvis, causing nonspecific symptoms such as localized pain, swelling, and weight loss. Atypically, ES can occur in extraosseous sites, such as the liver, kidneys, uterus, orbit, bone marrow, adrenal glands, and brain, where symptoms are determined by the tumor size and location. The characteristic histopathologic findings were small round blue cells in poorly differentiated tissue, which overlaps with several other malignancies including lymphoma and metastasis from nonbone tumors. Therefore, the diagnosis of ES requires a comprehensive analysis of pathology, immunochemistry, and genetics.

Histochemically, prominent membrane expression of CD99, along with frequent expression of NKX2.2, CD56, and synaptophysin, supports the diagnosis of ES. An absence of CD99 essentially eliminates the diagnosis of ES. Genetically, the most common chromosomal translocation in ES is between EWSR and FLT. Other fusion proteins were also reported, suggesting the heterogeneity in ES is driven by the genetic signatures to some extent.12 Multimodal treatment comprising surgery, chemotherapy, or radiotherapy remains to be the mainstay option. The prognosis is generally poor. Older age, metastasis, and high lactate dehydrogenase levels are unfavorable factors. Multidisciplinary treatment is beneficial to improve long-term survival.

Adult intradural-extramedullary ES is exceedingly rare. To our knowledge, this is the longest primary intraspinal ES lesion reported to date. The coexistence between extraosseous ES and neurosyphilis was also reported for the first time. Syphilis has been reported to correlate with an increased risk of various cancers. However, whether there is a causal relationship between them remains undetermined.13

Owing to low volume of CSF sample obtained, CSF cytology was not performed. Meningeal involvement of Ewing sarcoma can yield identifiable atypical cells in CSF. Atypical cells have high nuclear cytoplasmic ratios, with irregular nuclear outlines and multiple nucleoli.14 CSF cytology should not be omitted when the CSF sample volume is adequate.

Of note, the MALAT1-CYSLTR1 fusion protein is a notable finding. MALAT1 is a long noncoding RNA that mainly functions as a cell-cycle regulator. The overexpression of MALAT1 was correlated with metastasis and poor survival in various cancers. In ES cells, MALAT1 is transcriptionally activated through the SYK/c-MYC pathway. The silencing of MALAT1 robustly induced cell apoptosis and G1 cell-cycle arrest, implicating an oncogenic role of MALAT1 in ES pathogenesis.15 More functional studies are needed to dissect the roles of MALAT1-CYSLTR1 in ES.

This patient received chemotherapy using vincristine, cyclophosphamide, and epirubicin postsurgery. His back pain was abated. However, sphincter dysfunction and paraplegia were not improved. In summary, our case detailed the diagnosis of a patient with intradural-extramedullary ES and highlighted the value of spinal cord biopsy in progressive myelopathy of unknown causes.

Data Availability

Anonymized data not published within this study will be made available by request from any qualified investigator.

Study Funding

The authors report no targeted funding.

Disclosure

The authors report no disclosures relevant to the manuscript. Go to Neurology.org/N for full disclosures.

Acknowledgment

We thank the patient and his family for granting permission to publish this information.

Appendix Authors

Table

Footnotes

  • Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.

  • © 2021 American Academy of Neurology

References

  1. 1.↵
    1. Berger JR,
    2. Dean D
    . Neurosyphilis. Handb Clin Neurol. 2014;121:1461-1472.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Nagappa M,
    2. Sinha S,
    3. Taly AB, et al.
    Neurosyphilis: MRI features and their phenotypic correlation in a cohort of 35 patients from a tertiary care university hospital. Neuroradiology. 2013;55(4):379-388.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Dong H,
    2. Liu Z,
    3. Duan Y, et al.
    Syphilitic meningomyelitis misdiagnosed as spinal cord tumor: case and review. J Spinal Cord Med. 2021;44(5):789-793.
    OpenUrl
  4. 4.↵
    1. Cui L,
    2. Xu Z,
    3. Hou H
    . Diagnosis and treatment of spinal syphilitic gumma: a case report. Front Neurol. 2019;10:1352.
    OpenUrl
  5. 5.↵
    1. Yang C,
    2. Li G,
    3. Fang J,
    4. Liu H,
    5. Yang B,
    6. Xu Y
    . Spinal intramedullary syphilitic gumma: an unusual presentation of neurosyphilis. World Neurosurg. 2016;95:622 e617-622 e623.
    OpenUrl
  6. 6.↵
    1. Yuan JL,
    2. Wang WX,
    3. Hu WL
    . Clinical features of syphilitic myelitis with longitudinally extensive myelopathy on spinal magnetic resonance imaging. World J Clin Cases. 2019;7(11):1282-1290.
    OpenUrl
  7. 7.↵
    1. Koeller KK,
    2. Shih RY
    . Intradural extramedullary spinal neoplasms: radiologic-pathologic correlation. Radiographics. 2019;39(2):468-490.
    OpenUrl
  8. 8.↵
    1. Iunes EA,
    2. Stavale JN,
    3. de Cassia Caldas Pessoa R, et al.
    Multifocal intradural extramedullary ependymoma. Case report. J Neurosurg Spine. 2011;14(1):65-70.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Scantland JT,
    2. Gondim MJ,
    3. Koivuniemi AS,
    4. Fulkerson DH,
    5. Shih CS
    . Primary spinal intradural extraosseous ewing sarcoma in a pediatric patient: case report and review of the literature. Pediatr Neurosurg. 2018;53(4):222-228.
    OpenUrl
  10. 10.↵
    1. Murphy OC,
    2. Salazar-Camelo A,
    3. Jimenez JA, et al.
    Clinical and MRI phenotypes of sarcoidosis-associated myelopathy. Neurol Neuroimmunol Neuroinflamm. 2020;7(4):e722.
    OpenUrlAbstract/FREE Full Text
  11. 11.↵
    1. Krings T,
    2. Geibprasert S
    . Spinal dural arteriovenous fistulas. AJNR Am J Neuroradiol. 2009;30(4):639-648.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    1. Riggi N,
    2. Suva ML,
    3. Stamenkovic I
    . Ewing's sarcoma. N Engl J Med. 2021;384(2):154-164.
    OpenUrlCrossRef
  13. 13.↵
    1. Michalek AM,
    2. McLaughlin CC,
    3. Murphy D,
    4. Metzger BB
    . Historical and contemporary correlates of syphilis and cancer. Int J Epidemiol. 1994;23(2):381-385.
    OpenUrlCrossRefPubMed
  14. 14.↵
    1. Yu L,
    2. Craver R,
    3. Baliga M, et al.
    Isolated CNS involvement in Ewing's sarcoma. Med Pediatr Oncol. 1990;18(5):354-358.
    OpenUrlPubMed
  15. 15.↵
    1. Sun H,
    2. Lin DC,
    3. Cao Q, et al.
    Identification of a novel SYK/c-MYC/MALAT1 signaling pathway and its potential therapeutic value in ewing sarcoma. Clin Cancer Res. 2017;23(15):4376-4387.
    OpenUrlAbstract/FREE Full Text

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Abstract
    • Section 1
    • Section 2
    • Section 3
    • Section 4
    • Discussion
    • Study Funding
    • Disclosure
    • Acknowledgment
    • Appendix Authors
    • Footnotes
    • References
  • Figures & Data
  • Info & Disclosures
Advertisement

SARS-CoV-2 Vaccination Safety in Guillain-Barré Syndrome, Chronic Inflammatory Demyelinating Polyneuropathy, and Multifocal Motor Neuropathy

Dr. Jeffrey Allen and Dr. Nicholas Purcell

► Watch

Related Articles

  • Resident & Fellow Rounds: March 2022

Topics Discussed

  • All Spinal Cord
  • Spinal cord tumor

Alert Me

  • Alert me when eletters are published
Neurology: 100 (13)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise